Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

International Stem Cell Corp. (ISCO) Edges Ever Closer to First Real Therapeutic Solution for Halting & Even Reversing Parkinson’s

With the recent announcement from Australia’s version of the FDA, the Therapeutic Goods Administration, that pluripotent stem cell manufacturing innovator International Stem Cell Corp. (OTCQB: ISCO) has been cleared to start Phase I/IIa dose escalation clinical trials focused on the safety and efficacy of its human parthenogenetic neural stem cells (ISC-hpNSCs), the company has taken […]

Freedom Leaf, Inc. (FRLF) is Designed Around Growth Vision of Founders

Freedom Leaf, a leading marketing and business resource for the cannabis, industrial hemp, and medical marijuana industries, has its roots in the vision of its founders, representing decades of experience in the marijuana legalization movement. The company does not handle, grow, sell, or dispense marijuana or related products, but rather is a movement marketing company […]

Alternet Systems, Inc. (ALYI) Promoting Tech of the Future

Alternet Systems, Inc. (OTCQB: ALYI) is preparing people for a new age of digital living. The company, which invests in technological tools that enable and expedite commerce, is focused on elevating its customers’ – and partners’ – experience with multichannel payments, digital commerce and predictive analytics. By concentrating on improving efficiency, the company is pushing […]

International Stem Cell Corp. (ISCO) to Conduct Clinical Trial with One of the World’s Leading Brain Research Centers

International Stem Cell Corp., a clinical stage biotech company developing novel stem cell-based therapies, has signed a master clinical research agreement with the Florey Institute of Neuroscience and Mental Health to conduct phase I/IIa clinical trial, dose escalation trial of human parthenogenetic stem cells-derived neural stem cells (ISC-hpNSC) in Parkinson’s disease (PD) patients. ISCO said […]

Cherubim Interests (CHIT) Alternative Investment Opportunities Showing Growth Signs in Multiple Areas

Cherubim Interests, Inc. (OTC: CHIT) is an investment company with its energy and resources centered on single and multi-family dwellings for purchase. The company also targets undervalued commercial assets. Cherubim’s business model is geared toward becoming a leader in property management, alternative construction, multifamily real estate, and investment opportunities. A trademark of the company is […]

 

From Our Blog

Safe Pro Group Inc. (NASDAQ: SPAI) Joins Russell Microcap(R) Index, Signaling Growing Investor Recognition, Market Visibility

July 8, 2025

Safe Pro Group (NASDAQ: SPAI), an emerging provider of AI-powered security and threat detection solutions, announced its addition to the Russell Microcap(R) Index, effective after market close on June 27, 2025. The inclusion comes as part of FTSE Russell’s annual reconstitution, which ranks companies based on objective measures of market capitalization and style factors (https://ibn.fm/Bjka9). […]

Rotate your device 90° to view site.